Skip to content

Public FDA record

Z-0827-2015: Glucose Hexokinase (Liquid) Reagent For the in vitro quantitative determination of Glucose in serum.

Recall record Z-0827-2015 for JAS Diagnostics Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0827-2015
Company in FDA record
JAS Diagnostics Inc.
FDA classification date
Dec 18, 2014
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Product is not performing according to specifications. Control 2 does not consistently recover within its assigned range.

Source facts

Action
On October 23, 2014, JAS Diagnostics, Inc. sent out an IMPORTANT PRODUCT RECALL INFORMATION letter asking its consignees to discontinue use of the Glucose Hexokinase lots immediately. Customers are to contact the Service Department at 305-748-2762 or 305-748-2763 for information regarding reimbursement. Also, customers are to complete the attached Certificate of Destruction and return the document to JAS Diagnostics.
Initiated
2014-10-23
Root cause
Under Investigation by firm
Terminated
2015-02-26
Distribution
Worldwide Distribution -- US, including the states of NV, TN, TX, FL, GA, NY, NC, CA, MN, OR and Puerto Rico; and, the countries of France, Jamaica, Haiti, Cayman Islands, Trinidad & Tobago, and Ghana.
Recall number
Z-0827-2015
Recall status
Terminated
CDRH record ID
131170
FDA classified
2014-12-18
Recall event number
69622

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗